GO:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress: ER Stress-Induced Apoptosis, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0070059 describes the intrinsic apoptotic signaling pathway triggered by endoplasmic reticulum (ER) stress, a biological process that converts unresolved protein misfolding in the ER lumen into caspase-dependent cell death.
The pathway is initiated by three canonical ER stress sensors (PERK, ATF6, IRE1) and is executed through BAX/BAK-dependent mitochondrial outer membrane permeabilization and caspase activation.
ER stress-induced apoptosis is a central mechanism in cancer therapy sensitivity, acute kidney injury, neurodegeneration, and metabolic disease.
Key regulators include the BCL-2 family (BAX, BAK, BID, BIM, PUMA), CHOP/DDIT3, caspase-12 (rodent) / caspase-4 (human), and calcium signaling effectors.
Experimental dissection of GO:0070059 requires combining ER stress inducers (thapsigargin, tunicamycin) with CRISPR knockout, knock-in, and overexpression models to establish causality.
The pathway is immunologically relevant because ER stress-induced death can be immunogenic or tolerogenic depending on context, influencing anti-tumor immunity.

Description

The intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) is the series of intracellular molecular signals that link the accumulation of unfolded or misfolded proteins in the ER lumen to the execution phase of apoptosis. This process is a core component of the unfolded protein response (UPR) and represents one of the most important mechanisms by which cells decide between adaptation and death under proteotoxic stress. Because the ER is the entry point for secretory and membrane protein biogenesis, its functional integrity is essential for survival, and failure to restore ER homeostasis activates a dedicated apoptotic program. Researchers study GO:0070059 because it sits at the intersection of protein quality control, calcium homeostasis, redox biology, and cell death, and because its dysregulation contributes to cancer, kidney injury, neurodegeneration, and metabolic disorders. The pathway is also a major determinant of how tumor cells respond to chemotherapy and targeted agents, making it a high-value target for therapeutic modulation. In this article we synthesize the QuickGO definition with verified PubMed literature to provide a research-grade overview of the genes, mechanisms, disease links, and experimental methods relevant to GO:0070059.

intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress At A Glance

GO ID GO:0070059
GO term intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
Ontology biological_process
Synonym ER stress-induced apoptosis; apoptosis in response to ER stress; endoplasmic reticulum stress-induced apoptosis
Major function Converts ER protein-folding stress into intrinsic apoptotic cell death
Upstream sensors PERK (EIF2AK3), ATF6, IRE1 (ERN1)
Core effectors CHOP/DDIT3, BAX, BAK, caspases
Cellular context ER lumen stress, mitochondrial outer membrane permeabilization
Disease relevance Cancer, acute kidney injury, neurodegeneration, metabolic disease

What Is GO:0070059?

GO:0070059 is defined as the series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell, induced in response to a stimulus indicating ER stress, and ending when the execution phase of apoptosis is triggered. In simpler terms, it is the cell's decision-and-execution program that converts ER protein-folding stress into programmed cell death. The pathway is intrinsic (mitochondrial) in the sense that it converges on BCL-2 family-mediated mitochondrial outer membrane permeabilization and caspase activation, rather than on death receptor signaling.

Why Is intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress Important in Cell Biology?

GO:0070059 is important because it defines the mechanistic bridge between ER proteostasis and cell fate, and because this bridge is a therapeutic node in multiple human diseases. In cancer, the ability of tumor cells to evade or engage ER stress-induced apoptosis determines sensitivity to chemotherapy, oncolytic viruses, and targeted agents. In acute kidney injury, regulated cell death pathways including ER stress-driven apoptosis contribute to tubular injury and loss of renal function. In metabolic disease, suppression of beta-cell apoptosis under ER stress is a strategy to preserve insulin secretion. Understanding GO:0070059 therefore informs drug discovery, biomarker development, and the design of CRISPR-based disease models.
Defines a core cell-fate decision that determines whether proteotoxic stress is survived or executed as apoptosis.
Central to cancer therapy response, including sensitivity to oncolytic viruses and chemotherapeutics.
Contributes to acute kidney injury through regulated cell death of tubular epithelial cells.
Modulates beta-cell survival in metabolic disease, with metformin shown to suppress ER stress-induced apoptosis.
Influences immunogenicity of tumor cell death, affecting anti-tumor immune responses.
Provides mechanistic links to calcium signaling, oxidative stress, and mitochondrial dysfunction.
Serves as a target for pharmacological modulation by ER stress inducers and inhibitors.
Enables CRISPR-based causal testing of candidate regulators in disease-relevant cell models.
Relevant to spermatogenesis and germ cell homeostasis through apoptotic regulators.
Connects to innate immune signaling, as cGAS-STING activation can intersect with apoptotic programs.

What Happens During intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress?

ER stress sensing and UPR activation
In simple terms: The cell first detects that proteins are misfolding in the ER and turns on a stress alarm.
ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen, which is sensed by three principal transmembrane transducers: PERK (EIF2AK3), ATF6, and IRE1 (ERN1). Activation of these sensors initiates the unfolded protein response, which attempts to restore proteostasis by attenuating translation, increasing chaperone expression, and expanding ER folding capacity. If adaptation fails, the same sensors and their downstream transcription factors, notably CHOP/DDIT3, shift the program toward apoptosis. This sensing-to-decision transition is the entry point of GO:0070059.
Mitochondrial outer membrane permeabilization
In simple terms: The stress signal reaches the mitochondria and punches holes in them, committing the cell to die.
The intrinsic apoptotic arm of GO:0070059 converges on BCL-2 family proteins, where pro-apoptotic effectors BAX and BAK oligomerize and permeabilize the mitochondrial outer membrane. This permeabilization releases cytochrome c and other intermembrane space proteins, leading to apoptosome formation and caspase-9 activation. BH3-only proteins such as BIM, PUMA, and BID integrate ER stress signals and can be transcriptionally induced by CHOP, linking ER stress directly to mitochondrial apoptosis. The balance between anti-apoptotic BCL-2 proteins and BH3-only sensitizers determines whether the pathway proceeds.
Caspase activation and execution
In simple terms: Once the mitochondria are breached, executioner caspases dismantle the cell.
Following mitochondrial outer membrane permeabilization, cytochrome c binds APAF1 to form the apoptosome, which activates caspase-9, which in turn activates executioner caspases-3 and -7. In rodents, caspase-12 has been implicated as an ER-resident caspase activated by ER stress, while in humans caspase-4 is discussed in the context of ER stress-associated death. The execution phase involves cleavage of hundreds of substrates, resulting in the morphological and biochemical hallmarks of apoptosis. This terminal step defines the endpoint of GO:0070059.
Calcium and redox crosstalk
In simple terms: Calcium leaks and oxidative stress from the ER help push the cell toward death.
ER stress is frequently accompanied by disruption of ER calcium homeostasis and by oxidative stress, both of which can sensitize mitochondria to BAX/BAK-dependent permeabilization. Calcium transfer from ER to mitochondria can promote mitochondrial calcium overload and permeability transition, amplifying the apoptotic signal. Redox imbalance in the ER lumen also contributes to the activation of stress-responsive transcription factors that feed into the apoptotic program. These crosstalk mechanisms help explain why ER stress-induced apoptosis is sensitive to calcium and antioxidant modulation.
Immunogenic and context-dependent outcomes
In simple terms: How the cell dies can determine whether the immune system notices.
The immunogenicity of tumor cell death depends on the molecular context of the death program, and ER stress-associated apoptosis can influence whether dying cells elicit an immune response. In some settings, ER stress-induced apoptosis is tolerogenic, while in others it contributes to immunogenic cell death that supports anti-tumor immunity. Innate immune signaling pathways such as cGAS-STING can intersect with apoptotic programs, further shaping the outcome. This context dependence is a key reason why GO:0070059 is studied in immuno-oncology.

Key Genes Involved in GO:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress

The following genes and proteins represent the principal sensors, transducers, and effectors experimentally linked to GO:0070059.
GeneMajor RoleResearch Relevance
ERN1 (IRE1)ER stress sensor with endoribonuclease activityModulates sensitivity to oncolytic viruses and ER stress-induced death
EIF2AK3 (PERK)ER stress sensor that attenuates translationControls adaptive versus apoptotic fate under ER stress
ATF6ER stress sensor and transcription factorDrives chaperone and UPR gene expression
DDIT3 (CHOP)Pro-apoptotic transcription factorCentral mediator of ER stress-induced apoptosis
BAXPro-apoptotic BCL-2 effectorExecutes mitochondrial outer membrane permeabilization
BAKPro-apoptotic BCL-2 effectorCooperates with BAX in mitochondrial permeabilization
BCL2L11 (BIM)BH3-only sensitizerIntegrates ER stress signals into mitochondrial apoptosis
BBC3 (PUMA)BH3-only activatorPromotes apoptosis downstream of ER stress
BIDBH3-only protein linking death pathwaysAmplifies mitochondrial apoptotic signaling
CASP9Initiator caspaseForms apoptosome and activates executioner caspases
CASP3Executioner caspaseCleaves substrates during apoptosis
CASP4Human ER stress-associated caspaseDiscussed in ER stress-induced death
CASP12Rodent ER stress-associated caspaseModel-specific mediator of ER stress apoptosis
BCL2Anti-apoptotic guardianSets threshold for mitochondrial permeabilization
BCL2L1 (BCL-XL)Anti-apoptotic guardianCounteracts BAX/BAK activation
STING1Innate immune adaptorIntersects with apoptotic signaling
CGASCytosolic DNA sensorLinks innate immunity to apoptosis
MAPK8 (JNK)Stress kinaseModulates ER stress-induced apoptosis

How Is intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress Regulated?

GO:0070059 is regulated at multiple levels. Upstream, the UPR sensors PERK, ATF6, and IRE1 determine whether the cell adapts or commits to apoptosis, with PERK-mediated translation attenuation serving as a pro-survival brake that can be overwhelmed by sustained stress. Transcriptional regulation by CHOP/DDIT3 induces pro-apoptotic BH3-only proteins and represses anti-apoptotic BCL-2 family members, lowering the apoptotic threshold. Post-translational regulation includes phosphorylation of BCL-2 family proteins and caspase activation cascades. Pharmacological modulation is possible: metformin suppresses beta-cell apoptosis under ER stress by inhibiting protein translation, illustrating that translational control can regulate this pathway. In cancer, IRE1alpha activity modulates sensitivity to oncolytic virus-induced cell death, showing that sensor activity directly tunes the pathway. Innate immune signaling through cGAS-STING can also influence apoptotic outcomes, adding another layer of regulation.

intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress and Human Disease

GeneDisease / BiologyPotential Experimental Model
DDIT3 (CHOP)ER stress-induced apoptosis in cancer and metabolic diseaseKnockout in cancer cell lines with thapsigargin treatment
ERN1 (IRE1)Oncolytic virus sensitivity in bladder cancerKnockout in bladder cancer cells followed by viral infection
BAXMitochondrial apoptosis in AKI and cancerKnockout and point-mutation models
EIF2AK3 (PERK)Translational control in beta-cell survivalKnock-in of phospho-dead variants
CASP4Human ER stress-associated deathOverexpression and knockout in human cell lines
Cancer therapy sensitivity and resistance
ER stress-induced apoptosis is a major determinant of how cancer cells respond to chemotherapy, targeted therapy, and oncolytic viruses. Complex apoptotic signaling pathways, including those downstream of ER stress, shape cancer cell sensitivity to therapy, and tumors often adapt by upregulating anti-apoptotic BCL-2 proteins or by rewiring UPR signaling. IRE1alpha activity has been shown to modulate M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer, indicating that the sensor arm of GO:0070059 can be therapeutically exploited. The immunogenicity of tumor cell death further influences whether therapy engages anti-tumor immunity.
Acute kidney injury
Regulated cell death, including ER stress-associated apoptosis, contributes to acute kidney injury (AKI) and loss of renal tubular cells. The kidney is highly sensitive to proteotoxic and ischemic stress, and ER stress pathways are activated in tubular epithelial cells during injury. Targeting regulated cell death pathways, including those connected to GO:0070059, is an active area of nephrology research.
Metabolic disease and beta-cell survival
In metabolic disease, ER stress contributes to beta-cell apoptosis and loss of insulin secretion, and interventions that suppress this pathway can preserve beta-cell mass. Metformin has been reported to suppress beta-cell apoptosis under ER stress by inhibiting protein translation, providing a mechanistic link between translational control and GO:0070059. This makes the pathway a candidate target for diabetes research.
Neurodegeneration and germ cell biology
ER stress-induced apoptosis is implicated in neuronal loss in neurodegenerative conditions, where chronic proteotoxic stress overwhelms adaptive UPR capacity. In germ cell biology, apoptotic regulators during spermatogenesis act as killers or guards, and ER stress pathways can intersect with these decisions. These contexts highlight the broad physiological reach of GO:0070059.

From intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress-Related Genes to Experimental Models

Research QuestionSuitable Model
Is gene X required for ER stress-induced apoptosis?CRISPR knockout cell line plus thapsigargin or tunicamycin treatment
Does a disease-associated point mutation alter apoptotic threshold?CRISPR point-mutation knock-in isogenic line
Does a candidate effector localize to ER-mitochondria contacts?Tagged knock-in with fluorescent tag
Does overexpression of an anti-apoptotic gene block ER stress death?Doxycycline-inducible overexpression line
Which genes modulate oncolytic virus sensitivity?CRISPR library screening in cancer cells
Does innate immune signaling intersect with apoptosis?Knockout of STING1 or CGAS with ER stress induction

How to Study the intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress Process

MethodWhat It MeasuresTypical Application
RNA-seqTranscriptional changesUPR and apoptosis gene expression profiling
Ribo-seqTranslation efficiencyTranslational control under ER stress
PhosphoproteomicsKinase signaling changesPERK/IRE1 pathway mapping
Live-cell imagingOrganelle dynamics and MOMPReal-time apoptotic decision tracking
Annexin V flow cytometryPhosphatidylserine exposureApoptosis quantification
Caspase activity assayCaspase-3/7/9 activityExecution phase measurement
CRISPR library screeningGene essentiality and modifiersDiscovery of pathway regulators
TUNEL stainingDNA fragmentationApoptosis detection in tissue sections
Transcriptomic and translatomic profiling
RNA-seq and Ribo-seq can quantify UPR target genes and translation efficiency changes during ER stress, revealing how cells shift from adaptation to apoptosis. These methods identify CHOP/DDIT3 target genes and BH3-only protein induction that drive GO:0070059. Combining transcriptomics with CRISPR perturbations enables causal inference.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can measure caspase cleavage events, BCL-2 family protein abundance, and phosphorylation changes during ER stress-induced apoptosis. Phosphoproteomics is particularly useful for mapping PERK and IRE1 signaling nodes. These datasets help define the molecular signature of GO:0070059.
Imaging and organelle dynamics
Live-cell imaging with fluorescent reporters can track ER-mitochondria contact sites, calcium flux, and mitochondrial outer membrane permeabilization in real time. Tagged knock-in lines expressing fluorescent BAX or cytochrome c reporters allow single-cell resolution of the apoptotic decision. Imaging is essential for linking structural changes to pathway activation.
Functional apoptosis assays
Annexin V staining, caspase activity assays, and TUNEL staining quantify apoptotic execution downstream of ER stress. These assays are typically combined with ER stress inducers such as thapsigargin or tunicamycin to specifically interrogate GO:0070059. Dose-response and time-course designs help distinguish adaptive from apoptotic outcomes.

How CRISPR Can Be Used to Study GO:0070059 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress

Knockout

CRISPR knockout is the primary tool for testing whether a candidate gene is required for GO:0070059. By deleting genes such as DDIT3, BAX, or ERN1 and challenging cells with thapsigargin or tunicamycin, researchers can determine necessity for ER stress-induced apoptosis. Knockout of innate immune genes such as STING1 can reveal crosstalk between immune signaling and apoptotic execution.

Point Mutation

Point-mutation knock-in allows precise testing of phosphorylation sites, catalytic residues, and disease-associated variants in pathway components. For example, mutating PERK phosphorylation sites or BAX activation residues can reveal which molecular features are required for ER stress-induced apoptosis. Isogenic point-mutation lines control for genetic background and strengthen causal claims.

Knock-in

Tagged knock-in of genes such as BAX, cytochrome c, or CHOP enables live-cell imaging and proteomic pull-downs without overexpression artifacts. Knock-in of reporter cassettes under endogenous promoters provides physiological expression levels. This approach is valuable for tracking ER-mitochondria crosstalk during apoptosis.

Overexpression

Overexpression models are used to test sufficiency of pro-apoptotic or anti-apoptotic genes in modulating GO:0070059. Inducible overexpression of BCL-2 or BCL-XL can raise the apoptotic threshold, while overexpression of BH3-only proteins can sensitize cells to ER stress. Overexpression should be interpreted alongside knockout data to establish directionality.

How EDITGENE Supports intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress Research

Researchers studying intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress-related genes often need to determine whether a candidate gene is causally involved in the pathway, and at what step. Establishing causality requires isogenic, precisely engineered cell models that separate correlation from mechanism. EDITGENE provides end-to-end CRISPR services to generate such models and to support functional screening and bioinformatic analysis of GO:0070059.
Contact EDITGENE today to design your custom CRISPR model for intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress research.

Frequently Asked Questions About intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress

GO:0070059 is the Gene Ontology term for the intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, describing how ER protein misfolding triggers mitochondrial apoptosis.
Key genes include ERN1 (IRE1), EIF2AK3 (PERK), ATF6, DDIT3 (CHOP), BAX, BAK, BCL2L11 (BIM), BBC3 (PUMA), CASP9, CASP3, and BCL2 family members.
ER stress sensors PERK, ATF6, and IRE1 detect unfolded proteins and initiate the UPR; if adaptation fails, CHOP and BH3-only proteins activate BAX/BAK-dependent mitochondrial outer membrane permeabilization and caspases.
The UPR is an adaptive program that attempts to restore ER proteostasis, whereas GO:0070059 is the apoptotic program that executes cell death when adaptation fails.
It is implicated in cancer therapy response, acute kidney injury, metabolic disease including beta-cell loss, and neurodegeneration.
Common approaches include treating cells with thapsigargin or tunicamycin, measuring caspase activity and Annexin V staining, and using CRISPR knockout or knock-in models to test causality.
Caspase-12 has been implicated in rodents, while caspase-4 is discussed in human ER stress-associated death; species differences should be considered.
Yes, pharmacological modulation of UPR sensors, translation, and BCL-2 family proteins is an active strategy in cancer and metabolic disease.
IRE1alpha is an ER stress sensor whose activity modulates sensitivity to oncolytic viruses and influences cell death outcomes in cancer.
Innate immune signaling through cGAS-STING can intersect with apoptotic programs, shaping cell death and immune outcomes.

Conclusion

GO:0070059 provides a precise ontological framework for studying how ER protein-folding stress is converted into intrinsic apoptosis. The pathway integrates ER stress sensors, BCL-2 family decision points, mitochondrial permeabilization, and caspase execution, and it is causally implicated in cancer, kidney injury, metabolic disease, and neurodegeneration. Advances in CRISPR modeling, functional screening, and multi-omics profiling now make it feasible to dissect this pathway with high resolution and to identify therapeutic nodes. Researchers seeking to establish causality for candidate regulators of GO:0070059 can leverage EDITGENE's knockout, knock-in, point-mutation, overexpression, and screening services to accelerate discovery.

References

  1. 1. Linkermann A et al.. 2014. Regulated cell death in AKI.. J Am Soc Nephrol 25(12):2689-701 PMID: 24925726
  2. 2. Kim R et al.. 2024. Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy.. Cancers (Basel) 16(5) PMID: 38473345
  3. 3. Xu YR et al.. 2016. Regulators in the apoptotic pathway during spermatogenesis: Killers or guards?. Gene 582(2):97-111 PMID: 26861610
  4. 4. Rao RV et al.. 2004. Coupling endoplasmic reticulum stress to the cell death program.. Cell Death Differ 11(4):372-80 PMID: 14765132
  5. 5. Inoue R et al.. 2026. Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.. Metabolism 180:156607 PMID: 41962652
  6. 6. Kepp O et al.. 2009. The immunogenicity of tumor cell death.. Curr Opin Oncol 21(1):71-6 PMID: 19125021
  7. 7. Hu C et al.. 2025. IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer.. Cancer Drug Resist 8:41 PMID: 40843354
  8. 8. Xia N et al.. 2025. Porcine cGAS-STING signalling induced apoptosis negatively regulates STING downstream IFN response and autophagy via different mechanisms.. Virulence 16(1):2496436 PMID: 40310883
Contact Us
*
*
*
*
How did you hear about us: